Identifying subpopulations for subgroup analysis in a longitudinal clinical trial

Contemporary Clinical Trials

Volumn 29, Issue 6, 2008, Pages 817-822

  Moineddin, Rahim ^a,b   Butt, Debra A ^d   Tomlinson, George ^a,b   Beyene, Joseph ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d SCARBOROUGH HOSPITAL   (Canada)

Author keywords

Longitudinal study; Multilevel models; Random effect; Randomized controlled trial; Subgroup analysis

Indexed keywords

CREATININE; GABAPENTIN; PLACEBO;

ARTICLE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HOT FLUSH; HUMAN; LONGITUDINAL STUDY; PATIENT PARTICIPATION; PATIENT SELECTION; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AMINES; CALCIUM CHANNEL BLOCKERS; CYCLOHEXANECARBOXYLIC ACIDS; DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HOT FLASHES; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MIDDLE AGED; MODELS, STATISTICAL; POSTMENOPAUSE;

EID: 53649100997     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2008.07.002     Document Type: Article

References (14)

1. Assmann S.F., Pocock S.J., Enos L.E., and Kasten L.E. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 355 9209 (2000) 1064-1069
2. Diggle P.J., Heagerty P., Liang K.Y., and Zeger S.L. Analysis of longitudinal data. 2nd ed. (2002), Oxford University Press, New York
3. Singer J.D. Applied longitudinal data analysis: modeling change and event occurrence (2003), Oxford University Press, New York
4. Schuster C., and Von Eye A. Determining the meaning of parameters in multilevel models for longitudinal data. Int J Behav Dev 22 3 (1998) 475-491
5. Pandya K.J., Morrow G.R., Roscoe J.A., et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet 366 (2005) 818-824
6. Guttuso Jr. T., Kurlan R., McDermott M.P., and Kieburtz K. Gabapentin’s effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 101 2 (2003) 337-345
7. Reddy S.Y., Warner H., Guttuso T., et al. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial. Obstet Gynecol 108 1 (2006) 41-48
8. Butt D.A., Lock M., Lewis J.E., Ross S., and Moineddin R. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial. Menopause (N Y) 15 2 (2008) 310-318
9. Sloan J.A., Loprinzi C.L., Novotny P.J., et al. Methodologic lessons learned from hot flash studies. J Clin Oncol 19 23 (2001) 4280-4290
10. Loprinzi C.L., Michalak J.C., and Quella S.K. Megestrol acetate for the prevention of hot flashes. N Engl J Med 331 (1994) 347-352
11. Cook D.I., Gebski V.J., and Keech A.C. Subgroup analysis in clinical trials. Med J Aust 180 6 (2004) 289-291
12. Pocock S.J., Assmann S.E., Enos L.E., and Kasten L.E. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med 21 19 (2002) 2917-2930
13. Brookes S.T., Whitely E., Egger M., et al. Subgroup analyses in randomized trials: risks of subgroup-specific analyses: power and sample size for the interaction test. J Clin Epidemiol 57 3 (2004) 229-236
14. Rothwell P.M. Treating individuals 2: subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 365 9454 (2005) 176-186